Hereditary Cancer Testing Market By Cancer Type (Breast & Ovarian Cancer, Colorectal Cancer, Prostate Cancer, Pancreatic Cancer, Endocrine & Neuroendocrine Tumors, Renal Cancer, Others), By Test Type (Single-Gene Testing, Syndrome-Specific Panels, Comprehensive Multigene Panels, Whole-Exome Sequencing (WES), Whole-Genome Sequencing (WGS)), By Sample Type (Blood, Buccal Swab, Dried Blood Spot (DBS), Others), By Technology (Next-Generation Sequencing (NGS), Sanger Sequencing, Multiplex Ligation-dependent Probe Amplification, Quantitative PCR, RNA Sequencing, Long-Read Sequencing), By Distribution Channel (Physician-Ordered Testing, Institutional Programs, Insurer-Sponsored Programs, Direct-to-Consumer (DTC) Testing, Partner-Led Sales), and By End User (Hospitals & Clinics, Reference Laboratories, Oncology & Specialty Clinics, Genetic Counseling Centers & Networks, Online Genetic Testing Providers, Others), Global Market Size, Segmental Analysis, Regional Overview, Company Share Analysis, Leading Company Profiles and Market Forecast, 2025 – 2035.

---

Table of Contents

1. Methodology & Report Coverage

1.1. Definition & Objective

1.2. Market Evaluation & Forecast Parameter

1.3. Research Methodology

1.4. Data Validation Sources

1.4.1. Secondary Research

1.4.2. Primary Research

2. Market Overview

3. Hereditary Cancer Testing Market: Market Dynamics

3.1. Executive Summary

3.2. Market Driving Factors

3.2.1. What factors accelerate the adoption of multigene panels in hereditary cancer risk assessment?

3.2.2. How does growing awareness of personalized medicine increase hereditary cancer testing demand?

3.2.3. Which technological advancements in NGS improve accuracy, speed, and accessibility for testing?

3.3. Key industry pitfalls & challenges

3.3.1. What high costs of hereditary cancer testing limit accessibility across developing regions?

3.3.2. How do regulatory complexities slow down market entry for new genetic tests?

3.3.3. Which lack of trained genetic counselors hinders widespread hereditary testing adoption globally?

3.4. Market Opportunities

3.4.1. How can direct-to-consumer genetic testing expand access to hereditary cancer screening?

3.4.2. Which emerging markets present growth potential for hereditary cancer testing adoption?

3.4.3. How do population screening programs enable early detection and preventive healthcare strategies?

3.5. Porter’s Five Forces Analysis

3.6. PESTLE Analysis

3.7. Regulatory landscape

3.8. Investment Landscape

3.9. ESG Scenario

3.10. Competitive landscape

3.10.1. Company Market Share

3.10.2. Market Positioning

3.10.3. Strategy framework

3.10.4. Recent Acquisitions & Mergers

4. Hereditary Cancer Testing Market, Cancer Type Segment Analysis

4.1. Overview Dynamics

4.1.1. Market Revenue Share, By Cancer Type, 2025 & 2035

4.1.2. Key Market Trends, Growth Factors, & Opportunities

4.2. Breast & Ovarian Cancer

4.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.3. Colorectal Cancer

4.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.4. Prostate Cancer

4.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.5. Pancreatic Cancer

4.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.6. Endocrine & Neuroendocrine Tumors

4.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.7. Renal Cancer

4.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

4.8. Others

4.8.1. Market Size and Forecast, 2025-2035 (USD Billion)

5. Hereditary Cancer Testing Market, Test Type Segment Analysis

5.1. Overview

5.1.1. Market Revenue Share, By Test Type, 2025 & 2035

5.1.2. Key Market Trends, Growth Factors, & Opportunities

5.2. Single-Gene Testing

5.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.3. Syndrome-Specific Panels

5.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.4. Comprehensive Multigene Panels

5.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.5. Whole-Exome Sequencing (WES)

5.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

5.6. Whole-Genome Sequencing (WGS)

5.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

6. Hereditary Cancer Testing Market, Sample Type Segment Analysis

6.1. Overview

6.1.1. Market Revenue Share, By Sample Type, 2025 & 2035

6.1.2. Key Market Trends, Growth Factors, & Opportunities

6.2. Blood

6.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.3. Buccal Swab

6.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.4. Dried Blood Spot (DBS)

6.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

6.5. Others

6.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7. Hereditary Cancer Testing Market, Technology Segment Analysis

7.1. Overview

7.1.1. Market Revenue Share, By Technology, 2025 & 2035

7.1.2. Key Market Trends, Growth Factors, & Opportunities

7.2. Next-Generation Sequencing (NGS)

7.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.3. Sanger Sequencing

7.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.4. Multiplex Ligation-dependent Probe Amplification

7.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.5. Quantitative PCR

7.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.6. RNA Sequencing

7.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

7.7. Long-Read Sequencing

7.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

8. Hereditary Cancer Testing Market, Distribution Channel Segment Analysis

8.1. Overview

8.1.1. Market Revenue Share, By Distribution Channel, 2025 & 2035

8.1.2. Key Market Trends, Growth Factors, & Opportunities

8.2. Physician-Ordered Testing

8.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.3. Institutional Programs

8.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.4. Insurer-Sponsored Programs

8.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.5. Direct-to-Consumer (DTC) Testing

8.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

8.6. Partner-Led Sales

8.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

9. Hereditary Cancer Testing Market, End-user Segment Analysis

9.1. Overview

9.1.1. Market Revenue Share, By End-user, 2025 & 2035

9.1.2. Key Market Trends, Growth Factors, & Opportunities

9.2. Hospitals & Clinics

9.2.1. Market Size and Forecast, 2025-2035 (USD Billion)

9.3. Reference Laboratories

9.3.1. Market Size and Forecast, 2025-2035 (USD Billion)

9.4. Oncology & Specialty Clinics

9.4.1. Market Size and Forecast, 2025-2035 (USD Billion)

9.5. Genetic Counseling Centers & Networks

9.5.1. Market Size and Forecast, 2025-2035 (USD Billion)

9.6. Online Genetic Testing Providers

9.6.1. Market Size and Forecast, 2025-2035 (USD Billion)

9.7. Others

9.7.1. Market Size and Forecast, 2025-2035 (USD Billion)

10. Hereditary Cancer Testing Market, Region Segment Analysis

10.1. Overview

10.1.1. Global Market Revenue Share, By Region, 2025 & 2035

10.1.2. Global Market Revenue, By Region, 2025-2035 (USD Billion)

10.2. North America

10.2.1. North America Market Revenue, By Country, 2025-2035 (USD Billion)

10.2.2. North America Market Revenue, By Cancer Type, 2025-2035

10.2.3. North America Market Revenue, By Test Type, 2025-2035

10.2.4. North America Market Revenue, By Sample Type, 2025-2035

10.2.5. North America Market Revenue, By Technology, 2025-2035

10.2.6. North America Market Revenue, By Distribution Channel, 2025-2035

10.2.7. North America Market Revenue, By End-user, 2025-2035

10.2.8. The U.S.

10.2.8.1. U.S. Market Revenue, By Cancer Type, 2025-2035

10.2.8.2. U.S. Market Revenue, By Test Type, 2025-2035

10.2.8.3. U.S. Market Revenue, By Sample Type, 2025-2035

10.2.8.4. U.S. Market Revenue, By Technology, 2025-2035

10.2.8.5. U.S. Market Revenue, By Distribution Channel, 2025-2035

10.2.8.6. U.S. Market Revenue, By End-user, 2025-2035

10.2.9. Canada

10.2.9.1. Canada Market Revenue, By Cancer Type, 2025-2035

10.2.9.2. Canada Market Revenue, By Test Type, 2025-2035

10.2.9.3. Canada Market Revenue, By Sample Type, 2025-2035

10.2.9.4. Canada Market Revenue, By Technology, 2025-2035

10.2.9.5. Canada Market Revenue, By Distribution Channel, 2025-2035

10.2.9.6. Canada Market Revenue, By End-user, 2025-2035

10.3. Europe

10.3.1. Europe Market Revenue, By Country, 2025-2035(USD Billion)

10.3.2. Europe Market Revenue, By Cancer Type, 2025-2035

10.3.3. Europe Market Revenue, By Test Type, 2025-2035

10.3.4. Europe Market Revenue, By Sample Type, 2025-2035

10.3.5. Europe Market Revenue, By Technology, 2025-2035

10.3.6. Europe Market Revenue, By Distribution Channel, 2025-2035

10.3.7. Europe Market Revenue, By End-user, 2025-2035

10.3.8. Germany

10.3.8.1. Germany Market Revenue, By Cancer Type, 2025-2035

10.3.8.2. Germany Market Revenue, By Test Type, 2025-2035

10.3.8.3. Germany Market Revenue, By Sample Type, 2025-2035

10.3.8.4. Germany Market Revenue, By Technology, 2025-2035

10.3.8.5. Germany Market Revenue, By Distribution Channel, 2025-2035

10.3.8.6. Germany Market Revenue, By End-user, 2025-2035

10.3.9. France

10.3.9.1. France Market Revenue, By Cancer Type, 2025-2035

10.3.9.2. France Market Revenue, By Test Type, 2025-2035

10.3.9.3. France Market Revenue, By Sample Type, 2025-2035

10.3.9.4. France Market Revenue, By Technology, 2025-2035

10.3.9.5. France Market Revenue, By Distribution Channel, 2025-2035

10.3.9.6. France Market Revenue, By End-user, 2025-2035

10.3.10. U.K.

10.3.10.1. U.K. Market Revenue, By Cancer Type, 2025-2035

10.3.10.2. U.K. Market Revenue, By Test Type, 2025-2035

10.3.10.3. U.K Market Revenue, By Sample Type, 2025-2035

10.3.10.4. U.K Market Revenue, By Technology, 2025-2035

10.3.10.5. U.K Market Revenue, By Distribution Channel, 2025-2035

10.3.10.6. U.K. Market Revenue, By End-user, 2025-2035

10.3.11. Italy

10.3.11.1. Italy Market Revenue, By Cancer Type, 2025-2035

10.3.11.2. Italy Market Revenue, By Test Type, 2025-2035

10.3.11.3. Italy Market Revenue, By Sample Type, 2025-2035

10.3.11.4. Italy Market Revenue, By Technology, 2025-2035

10.3.11.5. Italy Market Revenue, By Distribution Channel, 2025-2035

10.3.11.6. Italy Market Revenue, By End-user, 2025-2035

10.3.12. Spain

10.3.12.1. Spain Market Revenue, By Cancer Type, 2025-2035

10.3.12.2. Spain Market Revenue, By Test Type, 2025-2035

10.3.12.3. Spain Market Revenue, By Sample Type, 2025-2035

10.3.12.4. Spain Market Revenue, By Technology, 2025-2035

10.3.12.5. Spain Market Revenue, By Distribution Channel, 2025-2035

10.3.12.6. Spain Market Revenue, By End-user, 2025-2035

10.3.13. Rest of Europe

10.3.13.1. Rest of Europe Market Revenue, By Cancer Type, 2025-2035

10.3.13.2. Rest of Europe Market Revenue, By Test Type, 2025-2035

10.3.13.3. Rest of Europe Market Revenue, By Sample Type, 2025-2035

10.3.13.4. Rest of Europe Market Revenue, By Technology, 2025-2035

10.3.13.5. Rest of Europe Market Revenue, By Distribution Channel, 2025-2035

10.3.13.6. Rest of Europe Market Revenue, By End-user, 2025-2035

10.4. Asia Pacific

10.4.1. Asia Pacific Market Revenue, By Country, 2025-2035(USD Billion)

10.4.2. Asia Pacific Market Revenue, By Cancer Type, 2025-2035

10.4.3. Asia Pacific Market Revenue, By Test Type, 2025-2035

10.4.4. Asia Pacific Market Revenue, By Sample Type, 2025-2035

10.4.5. Asia Pacific Market Revenue, By Technology, 2025-2035

10.4.6. Asia Pacific Market Revenue, By Distribution Channel, 2025-2035

10.4.7. Asia Pacific Market Revenue, By End-user, 2025-2035

10.4.8. China

10.4.8.1. China Market Revenue, By Cancer Type, 2025-2035

10.4.8.2. China Market Revenue, By Test Type, 2025-2035

10.4.8.3. China Market Revenue, By Sample Type, 2025-2035

10.4.8.4. China Market Revenue, By Technology, 2025-2035

10.4.8.5. China Market Revenue, By Distribution Channel, 2025-2035

10.4.8.6. China Market Revenue, By End-user, 2025-2035

10.4.9. Japan

10.4.9.1. Japan Market Revenue, By Cancer Type, 2025-2035

10.4.9.2. Japan Market Revenue, By Test Type, 2025-2035

10.4.9.3. Japan Market Revenue, By Sample Type, 2025-2035

10.4.9.4. Japan Market Revenue, By Technology, 2025-2035

10.4.9.5. Japan Market Revenue, By Distribution Channel, 2025-2035

10.4.9.6. Japan Market Revenue, By End-user, 2025-2035

10.4.10. India

10.4.10.1. India Market Revenue, By Cancer Type, 2025-2035

10.4.10.2. India Market Revenue, By Test Type, 2025-2035

10.4.10.3. India Market Revenue, By Sample Type, 2025-2035

10.4.10.4. India Market Revenue, By Technology, 2025-2035

10.4.10.5. India Market Revenue, By Distribution Channel, 2025-2035

10.4.10.6. India Market Revenue, By End-user, 2025-2035

10.4.11. Australia

10.4.11.1. Australia Market Revenue, By Cancer Type, 2025-2035

10.4.11.2. Australia Market Revenue, By Test Type, 2025-2035

10.4.11.3. Australia Market Revenue, By Sample Type, 2025-2035

10.4.11.4. Australia Market Revenue, By Technology, 2025-2035

10.4.11.5. Australia Market Revenue, By Distribution Channel, 2025-2035

10.4.11.6. Australia Market Revenue, By End-user, 2025-2035

10.4.12. South Korea

10.4.12.1. South Korea Market Revenue, By Cancer Type, 2025-2035

10.4.12.2. South Korea Market Revenue, By Test Type, 2025-2035

10.4.12.3. South Korea Market Revenue, By Sample Type, 2025-2035

10.4.12.4. South Korea Market Revenue, By Technology, 2025-2035

10.4.12.5. South Korea Market Revenue, By Distribution Channel, 2025-2035

10.4.12.6. South Korea Market Revenue, By End-user, 2025-2035

10.4.13. Singapore

10.4.13.1. Singapore Market Revenue, By Cancer Type, 2025-2035

10.4.13.2. Singapore Market Revenue, By Test Type, 2025-2035

10.4.13.3. Singapore Canada Market Revenue, By Sample Type, 2025-2035

10.4.13.4. Singapore Market Revenue, By Technology, 2025-2035

10.4.13.5. Singapore Market Revenue, By Distribution Channel, 2025-2035

10.4.13.6. Singapore Market Revenue, By End-user, 2025-2035

10.4.14. Rest of Asia Pacific

10.4.14.1. Rest of Asia Pacific Market Revenue, By Cancer Type, 2025-2035

10.4.14.2. Rest of Asia Pacific Market Revenue, By Test Type, 2025-2035

10.4.14.3. Rest of Asia Pacific Market Revenue, By Sample Type, 2025-2035

10.4.14.4. Rest of Asia Pacific Market Revenue, By Technology, 2025-2035

10.4.14.5. Rest of Asia Pacific Market Revenue, By Distribution Channel, 2025-2035

10.4.14.6. Rest of Asia Pacific Market Revenue, By End-user, 2025-2035

10.5. Latin America

10.5.1. Latin America Market Revenue, By Country, 2025-2035(USD Billion)

10.5.2. Latin America Market Revenue, By Cancer Type, 2025-2035

10.5.3. Latin America Market Revenue, By Test Type, 2025-2035

10.5.4. Latin America Market Revenue, By Sample Type, 2025-2035

10.5.5. Latin America Market Revenue, By Technology, 2025-2035

10.5.6. Latin America Market Revenue, By Distribution Channel, 2025-2035

10.5.7. Latin America Market Revenue, By End-user, 2025-2035

10.5.8. Brazil

10.5.8.1. Brazil Market Revenue, By Cancer Type, 2025-2035

10.5.8.2. Brazil Market Revenue, By Test Type, 2025-2035

10.5.8.3. Brazil Market Revenue, By Sample Type, 2025-2035

10.5.8.4. Brazil Market Revenue, By Technology, 2025-2035

10.5.8.5. Brazil Market Revenue, By Distribution Channel, 2025-2035

10.5.8.6. Brazil Market Revenue, By End-user, 2025-2035

10.5.9. Argentina

10.5.9.1. Argentina Market Revenue, By Cancer Type, 2025-2035

10.5.9.2. Argentina Market Revenue, By Test Type, 2025-2035

10.5.9.3. Argentina Market Revenue, By Sample Type, 2025-2035

10.5.9.4. Argentina Market Revenue, By Technology, 2025-2035

10.5.9.5. Argentina Market Revenue, By Distribution Channel, 2025-2035

10.5.9.6. Argentina Market Revenue, By End-user, 2025-2035

10.5.10. Mexico

10.5.10.1. Mexico Market Revenue, By Cancer Type, 2025-2035

10.5.10.2. Mexico Market Revenue, By Test Type, 2025-2035

10.5.10.3. Mexico Market Revenue, By Sample Type, 2025-2035

10.5.10.4. Mexico Market Revenue, By Technology, 2025-2035

10.5.10.5. Mexico Market Revenue, By Distribution Channel, 2025-2035

10.5.10.6. Mexico Market Revenue, By End-user, 2025-2035

10.5.11. Rest of Latin America

10.5.11.1. Rest of Latin America Market Revenue, By Cancer Type, 2025-2035

10.5.11.2. Rest of Latin America Market Revenue, By Test Type, 2025-2035

10.5.11.3. Rest of Latin America Market Revenue, By Sample Type, 2025-2035

10.5.11.4. Rest of Latin America Market Revenue, By Technology, 2025-2035

10.5.11.5. Rest of Latin America Market Revenue, By Distribution Channel, 2025-2035

10.5.11.6. Rest of Latin America Market Revenue, By End-user, 2025-2035

10.6. MEA

10.6.1. MEA Market Revenue, By Country, 2025-2035(USD Billion)

10.6.2. MEA Market Revenue, By Cancer Type, 2025-2035

10.6.3. MEA Market Revenue, By Test Type, 2025-2035

10.6.4. MEA Market Revenue, By Sample Type, 2025-2035

10.6.5. MEA Market Revenue, By Technology, 2025-2035

10.6.6. MEA Market Revenue, By Distribution Channel, 2025-2035

10.6.7. MEA Market Revenue, By End-user, 2025-2035

10.6.8. GCC Countries

10.6.8.1. GCC Countries Market Revenue, By Cancer Type, 2025-2035

10.6.8.2. GCC Countries Market Revenue, By Test Type, 2025-2035

10.6.8.3. GCC Countries Market Revenue, By Sample Type, 2025-2035

10.6.8.4. GCC Countries Market Revenue, By Technology, 2025-2035

10.6.8.5. GCC Countries Market Revenue, By Distribution Channel, 2025-2035

10.6.8.6. GCC Countries Market Revenue, By End-user, 2025-2035

10.6.9. South Africa

10.6.9.1. South Africa Market Revenue, By Cancer Type, 2025-2035

10.6.9.2. South Africa Market Revenue, By Test Type, 2025-2035

10.6.9.3. South Africa Market Revenue, By Sample Type, 2025-2035

10.6.9.4. South Africa Market Revenue, By Technology, 2025-2035

10.6.9.5. South Africa Market Revenue, By Distribution Channel, 2025-2035

10.6.9.6. South Africa Market Revenue, By End-user, 2025-2035

10.6.10. Rest of Middle-East & Africa

10.6.10.1. Rest of Middle-East & Africa Market Revenue, By Cancer Type, 2025-2035

10.6.10.2. Rest of Middle-East & Africa Market Revenue, By Test Type, 2025-2035

10.6.10.3. Rest of Middle-East & Africa Market Revenue, By Sample Type, 2025-2035

10.6.10.4. Rest of Middle-East & Africa Market Revenue, By Technology, 2025-2035

10.6.10.5. Rest of Middle-East & Africa Market Revenue, By Distribution Channel, 2025-2035

10.6.10.6. Rest of Middle-East & Africa Market Revenue, By End-user, 2025-2035

11. Company Profile

11.1. Myriad Genetics, Inc.

11.1.1. Business Overview

11.1.2. Financial Performance

11.1.3. Product/Service Offerings

11.1.4. Strategies & recent developments

11.1.5. SWOT Analysis

11.2. Invitae Corporation

11.2.1. Business Overview

11.2.2. Financial Performance

11.2.3. Product/Service Offerings

11.2.4. Strategies & recent developments

11.2.5. SWOT Analysis

11.3. Fulgent Genetics, Inc.

11.3.1. Business Overview

11.3.2. Financial Performance

11.3.3. Product/Service Offerings

11.3.4. Strategies & recent developments

11.3.5. SWOT Analysis

11.4. Ambry Genetics Corporation

11.4.1. Business Overview

11.4.2. Financial Performance

11.4.3. Product/Service Offerings

11.4.4. Strategies & recent developments

11.4.5. SWOT Analysis

11.5. GeneDx, Inc.

11.5.1. Business Overview

11.5.2. Financial Performance

11.5.3. Product/Service Offerings

11.5.4. Strategies & recent developments

11.5.5. SWOT Analysis

11.6. Guardant Health, Inc.

11.6.1. Business Overview

11.6.2. Financial Performance

11.6.3. Product/Service Offerings

11.6.4. Strategies & recent developments

11.6.5. SWOT Analysis

11.7. Qiagen N.V.

11.7.1. Business Overview

11.7.2. Financial Performance

11.7.3. Product/Service Offerings

11.7.4. Strategies & recent developments

11.7.5. SWOT Analysis

11.8. SOPHiA GENETICS SA

11.8.1. Business Overview

11.8.2. Financial Performance

11.8.3. Product/Service Offerings

11.8.4. Strategies & recent developments

11.8.5. SWOT Analysis

11.9. Prenetics Ltd.

11.9.1. Business Overview

11.9.2. Financial Performance

11.9.3. Product/Service Offerings

11.9.4. Strategies & recent developments

11.9.5. SWOT Analysis

11.10. GRAIL, Inc.

11.10.1. Business Overview

11.10.2. Financial Performance

11.10.3. Product/Service Offerings

11.10.4. Strategies & recent developments

11.10.5. SWOT Analysis

11.11. PathAI, Inc.

11.11.1. Business Overview

11.11.2. Financial Performance

11.11.3. Product/Service Offerings

11.11.4. Strategies & recent developments

11.11.5. SWOT Analysis

11.12. Color Genomics, Inc.

11.12.1. Business Overview

11.12.2. Financial Performance

11.12.3. Product/Service Offerings

11.12.4. Strategies & recent developments

11.12.5. SWOT Analysis

11.13. Blueprint Genetics Oy

11.13.1. Business Overview

11.13.2. Financial Performance

11.13.3. Product/Service Offerings

11.13.4. Strategies & recent developments

11.13.5. SWOT Analysis

11.14. Counsyl, Inc.

11.14.1. Business Overview

11.14.2. Financial Performance

11.14.3. Product/Service Offerings

11.14.4. Strategies & recent developments

11.14.5. SWOT Analysis

11.15. Natera, Inc.

11.15.1. Business Overview

11.15.2. Financial Performance

11.15.3. Product/Service Offerings

11.15.4. Strategies & recent developments

11.15.5. SWOT Analysis